TABLE 2.
List of the top 5 significantly enriched Reactome and KEGG pathways and their corresponding proteins in AD versus Old platelets sorted after adjusted p-value.
| Reactome Pathway | Proteins | FDR value |
|---|---|---|
| Innate Immune System | PYGB, PGRMC1, ARPC3, SKP1, RAC2, SNAP23, PSMB1, STOM, PSMB4, ARPC5, PA2G4, UBB, PSMD2, UBA7, RAC1, CYB5R3, RAB14, PSMB8, APRT, TXNDC5, PGM2, GRB2, ALAD, ARPC1B, PTPN6, NAPRT | 4.72E-11 |
| Immune System | PYGB, PGRMC1, ARPC3, SKP1, RAC2, SNAP23, PSMB1, STOM, PSMB4, STAT5B, EIF4A1, ARPC5, PA2G4, UBB, PSMD2, TCP1, UBE2O, UBA7, TUBA8, RAC1, CYB5R3, RAB14, PSMB8, APRT, TXNDC5, PGM2, GRB2, ALAD, ARPC1B, PTPN6, BCAP31, NAPRT | 1.41E-09 |
| Neutrophil degranulation | PYGB, PGRMC1, SNAP23, PSMB1, STOM, ARPC5, PA2G4, PSMD2, RAC1, CYB5R3, RAB14, APRT, TXNDC5, PGM2, ALAD, PTPN6, NAPRT | 5.92E-09 |
| Signaling by the B Cell Receptor (BCR) | SKP1, PSMB1, PSMB4, UBB, PSMD2, PSMB8, GRB2, PTPN6 | 1.24E-05 |
| RHO GTPase Effectors | ARPC3, RAC2, ARPC5, YWHAG, ROCK2, TUBA8, RAC1, MYLK, GRB2, PAFAH1B1, ARPC1B | 1.37E-05 |
| KEGG Pathway | ||
| Parkinson disease | PPIF, PSMB1, PSMB4, UBB, PSMD2, UBA7, TUBA8, ATP5C1, VDAC2 | 2.30E-04 |
| Prion disease | PPIF, RAC2, PSMB1, PSMB4, PSMD2, TUBA8, ATP5C1, VDAC2 | 2.30E-03 |
| Proteasome | PSMB1, PSMB4, PSMD2, PSMB8 | 2.90E-03 |
| Regulation of actin cytoskeleton | ARPC3, RAC2, ARPC5, ROCK2, MYLK, TMSB4X, ARPC1B | 2.90E-03 |
| Shigellosis | ARPC3, SKP1, SEPT11, ARPC5, UBB, ROCK2, ARPC1B | 2.90E-03 |